Atypical hemolytic-uremic syndrome due to scleroderma renal crisis treated with eculizumab

被引:1
|
作者
Skonieczny, Piotr [1 ]
Wojteczek, Anna [2 ]
Zdrojewski, Zbigniew [2 ]
Debska-Slizien, Alicja [1 ]
机构
[1] Med Univ Gdansk, Dept Nephrol Transplantol & Internal Dis, Gdansk, Poland
[2] Med Univ Gdansk, Dept Internal Dis Connect Tissue Dis & Geriatr, Gdansk, Poland
关键词
D O I
10.20452/pamw.16385
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Eculizumab in Atypical Hemolytic-Uremic Syndrome
    Ring, Troels
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1377 - 1378
  • [2] Eculizumab in Atypical Hemolytic-Uremic Syndrome Reply
    Legendre, Christophe M.
    Licht, Christoph
    Loirat, Chantal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1379 - 1380
  • [3] Eculizumab for Atypical Hemolytic-Uremic Syndrome.
    Nuernberger, Jens
    Witzke, Oliver
    Saez, Anabelle Opazo
    Vester, Udo
    Baba, Hideo Andreas
    Kribben, Andreas
    Zimmerhackl, Lothar Bernd
    Janecke, Andreas R.
    Nagel, Mato
    Kirschfink, Michael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 542 - 544
  • [4] Gemcitabine-Associated Atypical Hemolytic-Uremic Syndrome Treated with Eculizumab
    Plesa, A.
    Suarez, A.
    [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2020, 73 (01): : 77 - 78
  • [5] Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome.
    Gruppo, Ralph A.
    Rother, Russell P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 544 - 546
  • [6] More on Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome
    Shin, Jae Il
    Lee, Jae Seung
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20): : 2142 - 2143
  • [7] Prophylactic Eculizumab after Renal Transplantationin Atypical Hemolytic-Uremic Syndrome.
    Zimmerhackl, Lothar Bernd
    Hofer, Johannes
    Cortina, Gerard
    Mark, Walter
    Wuerzner, Reinhard
    Jungraithmayr, Therese C.
    Khursigara, Gus
    Kliche, Kay O.
    Radauer, Wolfgang
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (18): : 1746 - 1748
  • [8] ATYPICAL HEMOLYTIC UREMIC SYNDROME TREATED WITH ECULIZUMAB
    Khawar, M. U.
    Bhutta, U.
    Haragsim, L.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 410 - 410
  • [9] More on Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome Reply
    Gruppo, Ralph A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20): : 2143 - 2143
  • [10] Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
    Legendre, C. M.
    Licht, C.
    Muus, P.
    Greenbaum, L. A.
    Babu, S.
    Bedrosian, C.
    Bingham, C.
    Cohen, D. J.
    Delmas, Y.
    Douglas, K.
    Eitner, F.
    Feldkamp, T.
    Fouque, D.
    Furman, R. R.
    Gaber, O.
    Herthelius, M.
    Hourmant, M.
    Karpman, D.
    Lebranchu, Y.
    Mariat, C.
    Menne, J.
    Moulin, B.
    Nuernberger, J.
    Ogawa, M.
    Remuzzi, G.
    Richard, T.
    Sberro-Soussan, R.
    Severino, B.
    Sheerin, N. S.
    Trivelli, A.
    Zimmerhackl, L. B.
    Goodship, T.
    Loirat, C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23): : 2169 - 2181